NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsMediumNeutral
Announced Tue, 12 May · 19:46 IST

Neuland Laboratories Limited has informed the Exchange about Link of Recording

Investor Communications View source PDF

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.5%1-day move
₹17100.00
prior close
₹18305.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-4.3-4.7-4.7-4.3-2.5-3.5-4.7-2.7-2.7-2.5-1.2-0.2+11.0
Up moveDown movePending
AI summary

Neuland Laboratories Limited has submitted a regulatory disclosure informing BSE and NSE about the availability of audio recordings from their earnings call held on May 12, 2026. The call covered the quarter and fiscal year ended March 31, 2026. The company has provided a web link where investors can access the recordings. This filing is made pursuant to Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The actual content of the earnings call (including any guidance, numbers, or discussion points) is not included in this disclosure.

Likely market impact

This is a routine procedural filing providing access to earnings call recordings. It does not contain new financial information or guidance that would directly impact the stock. Investors interested in the company's Q4/FY2026 performance can access the full recordings at the provided link.